MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
about
Tying malaria and microRNAs: from the biology to future diagnostic perspectivesMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsInteraction of drugs of abuse and microRNA with HIV: a brief reviewPaving the path to HIV neurotherapy: Predicting SIV CNS diseaseThe emerging role of long non-coding RNAs in HIV infection.Non-coding RNAs and HIV: viral manipulation of host dark matter to shape the cellular environment.Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control StudyMicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1Short Communication: HIV-1 Infection Suppresses Circulating Viral Restriction microRNAsThe effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.Identification of Host Micro RNAs That Differentiate HIV-1 and HIV-2 Infection Using Genome Expression Profiling TechniquesDichotomous miR expression and immune responses following primary blood-stage malaria.MicroRNAs associated with inflammation in shoulder tendinopathy and glenohumeral arthritis.MicroRNAs, HIV and HCV: a complex relation towards pathology.Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.Anti-HIV microRNA expression in a novel Indian cohort.Non-coding RNAs and retroviruses.Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients.
P2860
Q26765405-275F3AA2-5EA2-4F02-B0E7-ADCEC3B2D315Q26773183-D4389102-9829-4CAB-80F3-75721774BC06Q26781552-03E81E13-B6FA-4FB1-8C87-6F5B18BB2BDEQ26852969-946ECCF6-D42A-443E-9DAD-03B3DA993891Q30377278-D2829C92-74C2-489F-A3FC-0A673EF4546BQ35219072-7BD04350-0C27-419E-8501-E1D5DE8278F4Q35806035-50ADCD53-A260-49FB-8A0B-B74F96899B0AQ36694035-A6180B5B-4193-4608-997D-FF1E930ABA09Q36756161-6F7C7D07-8494-4940-857D-39A5A3FC85CBQ36828738-953BD22C-130F-4615-9800-F3F3500ED370Q36946996-DD18CA4B-F5EB-4D80-82DE-9CF44CC6B701Q38645943-B540EE89-9BC1-43DF-B010-349E5DAC9362Q38716244-166DD2E5-B3A0-40F1-B787-475D765869F5Q38802349-727D9C91-C42B-4979-AE65-31877B779AA7Q40129315-2A9BEA10-0450-4A5F-92A6-809BA12762F0Q40692790-58FA6B0E-2578-416D-9424-7443EADF9AF8Q49236374-B4DFB6DA-77C4-4856-8880-C915CDECC4EFQ52716853-AD24B664-771B-4619-B4AD-2C7907C94ED3
P2860
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@ast
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@en
type
label
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@ast
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@en
prefLabel
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@ast
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@en
P2093
P2860
P50
P356
P1433
P1476
MicroRNAs differentially prese ...... reduce HIV infection in vitro
@en
P2093
Gabriela Turk
Heribert Stoiber
Jorge Quarleri
Mauricio Carobene
Natalia Laufer
Pedro Cahn
Regina Grillari-Voglauer
Rita Reynoso
Roland Werner
Rossella Monteforte
P2860
P2888
P356
10.1038/SREP05915
P407
P577
2014-08-01T00:00:00Z
P5875
P6179
1034406017